176 related articles for article (PubMed ID: 36686701)
1. Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma.
Hong L; Wang X; Cui W; Wang F; Shi W; Yu S; Luo Y; Zhong L; Zhao X
Front Pharmacol; 2022; 13():1098136. PubMed ID: 36686701
[No Abstract] [Full Text] [Related]
2. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment.
Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X
Front Immunol; 2022; 13():903758. PubMed ID: 36016939
[TBL] [Abstract][Full Text] [Related]
3.
Zheng Y; Zhang Z; Li X; Wu L; Liu X; Liu L; Chen J; Wei D
Front Biosci (Landmark Ed); 2023 Oct; 28(10):257. PubMed ID: 37919058
[TBL] [Abstract][Full Text] [Related]
4. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
5. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY
Front Oncol; 2021; 11():675545. PubMed ID: 34249715
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
[TBL] [Abstract][Full Text] [Related]
7. Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma.
Fei X; Hu C; Wang X; Lu C; Chen H; Sun B; Li C
Front Cell Dev Biol; 2021; 9():751490. PubMed ID: 34820377
[TBL] [Abstract][Full Text] [Related]
8. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma.
Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ
Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma.
Zheng Z; Zhang Q; Wu W; Xue Y; Liu S; Chen Q; Lin D
Front Genet; 2021; 12():690509. PubMed ID: 34367250
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
11. Comprehensive analysis of m6A modification patterns and m6A-related lncRNAs as potential biomarkers in lung adenocarcinoma.
Wang S; Gu X; Xu D; Liu B; Qin K; Yuan X
Environ Toxicol; 2024 Apr; 39(4):2285-2303. PubMed ID: 38148718
[TBL] [Abstract][Full Text] [Related]
12. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment.
Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z
J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of an autophagy-related long non-coding RNA signature as a prognostic biomarker for patients with lung adenocarcinoma.
Jiang A; Liu N; Bai S; Wang J; Gao H; Zheng X; Fu X; Ren M; Zhang X; Tian T; Ruan Z; Liang X; Yao Y
J Thorac Dis; 2021 Feb; 13(2):720-734. PubMed ID: 33717544
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma.
Yao J; Chen X; Liu X; Li R; Zhou X; Qu Y
Cancer Cell Int; 2021 Jul; 21(1):340. PubMed ID: 34217273
[TBL] [Abstract][Full Text] [Related]
15. ASMTL-AS1 impedes the malignant progression of lung adenocarcinoma by regulating SAT1 to promote ferroptosis.
Sui X; Hu N; Zhang Z; Wang Y; Wang P; Xiu G
Pathol Int; 2021 Nov; 71(11):741-751. PubMed ID: 34658100
[TBL] [Abstract][Full Text] [Related]
16. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
18. Prognostic markers of ferroptosis-related long non-coding RNA in lung adenocarcinomas.
Mao K; Tang R; Wu Y; Zhang Z; Gao Y; Huang H
Front Genet; 2023; 14():1118273. PubMed ID: 36923797
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
Ma C; Li F; Luo H
Ann Transl Med; 2021 Jul; 9(13):1058. PubMed ID: 34422970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
